Abstract:Disease progression in a cancer patient are identified by a number of indications in the form of loco-regional relapse, distant metastasis etc. Biomarkers play an essential role in early identification of these indications. The biomarkers can influence how a particular cancer behaves and how it may respond to a specific treatment, e.g., the survival probability of breast cancer patients diagnosed with HER2 positive status is different from the same with HER2 negative status. Researches have shown that the genetic mutations are often inconsistent across tumours and this is depicted in the form of bimodal and multi-modal expression values. So, the heterogeneity of the biomarker statuses or levels should be taken into consideration while modelling the survival outcome. This heterogeneity factor which is often unobserved, is called frailty. In the presence of competing events, the scenario becomes more complex as only one of them can occur, which will censor the occurrence of other events. Incorporating independent frailties of each biomarker status for every cause of indications will not portray the complete picture of heterogeneity. The events indicating cancer progression are likely to be inter-related. So, the correlation should be incorporated through the frailties of different events. The process can be performed for a single biomarker using a competing risk model with correlated frailty and estimates are obtained using Expectation-Maximization algorithm. Based on the estimated variance of the frailty, the threshold levels of a biomarker are utilised as early detection tool of the disease progression or death. For multiple biomarkers, we have employed a sequential proportional hazard model using p-value combination method which will incorporate the correlations between the biomarkers. With the extensive algorithm in R, we have obtained the threshold levels of activity of multiple biomarkers in a competing risk scenario.

Penalized estimation in parametric frailty model

Frailty Models for Pneumonia to Death with a Left‐censored Covariate

CASE-CONTROL SURVIVAL ANALYSIS WITH A GENERAL SEMIPARAMETRIC SHARED FRAILTY MODEL - A PSEUDO FULL LIKELIHOOD APPROACH

A Comparison of Parameter Estimation Methods for Shared Frailty Models

Frailty model with change points for survival analysis

A study on comparisons of additive regression frailty models to counter heterogeneity: Bayesian strategies and case study

PENALIZED VARIABLE SELECTION PROCEDURE FOR COX MODELS WITH SEMIPARAMETRIC RELATIVE RISK

Penalized Variable Selection with Broken Adaptive Ridge Regression for Semi-competing Risks Data

On the Addams family of discrete frailty distributions for modelling multivariate case I interval-censored data

Frailty Model with Change Point for Survival Analysis

On the Addams family of discrete frailty distributions for modeling multivariate case I interval-censored data

General Semiparametric Shared Frailty Model: Estimation and Simulation with frailtySurv

Tutorial in Joint Modeling and Prediction: a Statistical Software for Correlated Longitudinal Outcomes, Recurrent Events and a Terminal Event

Birnbaum–Saunders frailty regression models for clustered survival data

An Accelerated Failure Time Regression Model for Illness-Death Data: A Frailty Approach

A penalized likelihood approach for efficiently estimating a partially linear additive transformation model with current status data

Practical implementation of frailty models in Mendelian risk prediction

Semiparametric estimation for the functional additive hazards model

Impact of model misspecification in shared frailty survival models

A modified risk detection approach of biomarkers by frailty effect on multiple time to event data

Stochastic frailty models for modeling and forecasting mortality